The London Clinic becomes the UK’s first hospital to introduce GI Genius™ artificial intelligence device for colonoscopy
Wednesday, November 11, 2020
The London Clinic, a leading independent hospital and charity, located in London’s Harley Street Medical Area, is the first hospital in the UK and one of the first in the world, to employ GI Genius™, a revolutionary device that uses artificial intelligence (AI) to enhance the quality of colonoscopies, offering a new solution for the early detection of colorectal cancer.
The GI Genius™ module – produced by global medical device company Medtronic – is the first system worldwide to use AI to detect colorectal polyps. The device acts as a second observer during colonoscopies, helping to assist doctors by identifying lesions and small mucosal abnormalities that may signal cancer.
Studies have shown that having a second observer can increase polyp detection rates. Every 1 percent increase in adenoma detection rate reduces the risk of colorectal cancer by 3 percent.[1]
The pioneering GI Genius™ system works by analysing the video stream during colonoscopy, using advanced AI to highlight the presence of pre-cancerous lesions with a visual marker in real-time. The device offers the potential to improve diagnosis and outcomes for patients with colorectal cancer.
Dr Rehan Haidry, Consultant Gastroenterologist at The London Clinic, said: “We are thrilled to introduce the GI Genius™ system at The London Clinic. The system represents an important advancement in technology and is a crucial step in the fight against colorectal cancer, supporting both patients and doctors.
“The technology is incredibly powerful and is proven to be extremely precise in identifying lesions in the colonic mucosa that can be difficult to detect. Some polyps can be very small, and during colonoscopy procedures you are examining the colon, which is five feet long, so it’s vital to be as thorough and diligent as possible.
“Having a second set of eyes that can pick up the smallest change in real-time means we can focus our attention on the right places, which can be life-saving for patients.”
Colorectal cancer (also known as bowel cancer) is the fourth most common cancer in the UK – and the second biggest cancer killer in the country, claiming more than 16,000 lives a year.[2] Colorectal cancer is treatable and curable, especially if diagnosed early.[3] However, this drops significantly as the disease develops. This is why early, accurate detection is crucial.
The best prevention is regular screening tests such as colonoscopy, which helps to examine the inside of the bowels to identify the presence of polyps (or adenomas), which may transform into carcinomas (cancer) if not detected and removed early. Over 90% of colorectal carcinomas are adenocarcinomas which can be detected in colonoscopy screening procedures.[4]
Research shows that the adenoma detection rate (ADR) can vary greatly between endoscopists.[5] However, a recently released randomised trial found that computer-aided polyp detection (CADe) can increase adenoma detection rates (ADR) versus high-definition (HD) colonoscopy alone. Much of the improved performance was in the detection of smaller polyps (<10 mm)[6], which are more likely to be missed during screening.
The JAG accredited Endoscopy team at The London Clinic are proud to be the first hospital in the UK and one of the first in the world, to be utilising this pioneering technology to significantly improve detection and outcomes for patients with colorectal cancer.
FOR MORE INFORMATION, MEDIA INTERVIEWS AND IMAGES, CONTACT:
Daphne Power
Media Campaigns Officer
The London Clinic
07598 790732
d.power@thelondonclinic.co.uk
Notes to Editors
About The London Clinic
The London Clinic is the UK’s leading private charitable hospital, situated in Harley Street, the heart of London’s medical district. Opened in February 1932 by the Duke and Duchess of York (later becoming King George VI), The London Clinic has been at the forefront of healthcare for close to 90 years. Our services are provided across seven buildings housing ten theatres, 234 beds, consulting rooms and a wide range of diagnostic services, including the latest 3T MRI scanner. The Duchess of Devonshire Wing, The London Clinic’s custom-built cancer centre, spans eight floors, offering access to state-of-the-art radiotherapy and chemotherapy suites, along with Europe’s largest private stem cell collection and storage facility. We were the first independent hospital in the UK to gain the Joint Accreditation Committee ISCT Europe and EBMT (JACIE) accreditation in recognition of our quality standards in stem cell work. As a full-service hospital, The London Clinic offers the most comprehensive range of services of any UK private hospital, including a 13 bed, Level 3 Intensive Care Unit and in-house pathology laboratory. We employ over 1,300 expert nurses, allied healthcare professionals, doctors and support roles. Our 600 world-class consultants specialise in cancer care, digestive diseases, orthopaedics (including hips, knees, shoulders and fingers with on-site physiotherapy rehabilitation), neurology, cosmetic surgery, liver services, gastroenterology, urology, endoscopy, diabetes, haematology and endocrinology. As a charity, The London Clinic reinvests all profits to further our mission of advancing healthcare within our hospital and for the benefit of the healthcare community. We were the first private hospital in the UK to introduce robotic surgery for prostate cancer and SpyGlass technology for endoscopy, and are the only UK hospital supporting the phase three international clinical trial for Intra Operative Radiotherapy on glioblastoma multiforme. We continue to invest significantly in the education of our people, supporting nurses to complete their degrees and fellows to become consultants. Find out more at www.thelondonclinic.co.uk. Follow us at linkedin.com/company/the-london-clinic and twitter.com/thelondonclinic.
About GI Genius™
GI Genius is produced by Medtronic plc (NYSE:MDT), the global leader in medical technology. To bring this technology to market, Medtronic entered a worldwide distribution agreement with Cosmo Pharmaceuticals. Cosmo Pharmaceuticals is the sole manufacturer of the artificial intelligent software and device. GI Genius intelligent endoscopy module is CE-marked and is available in select European markets. GI Genius intelligent endoscopy module does not have FDA clearance and therefore is not available for sale in the United States.
About Harley Street Medical Area
The Howard de Walden Estate is the guardian of the Harley Street Medical Area and has been supporting and nurturing medical excellence in this historic part of London for 200 years. The Harley Street Medical Area is a collective of hospitals, clinics and specialists who deliver outstanding patient care through pioneering treatments and cutting-edge technologies. With over 5000 medical specialists and over 250 clinics working within 92 acres of Marylebone, central London. The Harley Street Medical Area brings together a community of medical professionals, providing access to the best medical treatments and services in the world.
[1] Aslanian HR, Shieh FK, Chan FW et al. Am J Gastroenterol. 2013 Feb;108(2):166-72. doi:10.1038/ajg.2012.237
[2] Bowel Cancer UK Website: https://www.bowelcanceruk.org.uk/media/
[3] Bowel Cancer UK Website: https://www.bowelcanceruk.org.uk/media/
[4] https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/detection.html
[5] Corley DA, Jenson CD, Marks AR JR, et al. NEJM 2014;370:1298-306.
[6] https://www.medtronic.com/content/dam/covidien/library/emea/en/product/gi-solutions/weu-lit-review-repici.pdf
Julia Price
Public Relations Consultant
+44 (0) 7737 864 878
juliaprice.co.uk